Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$225.79 - $275.2 $9,031 - $11,008
-40 Reduced 30.77%
90 $21,000
Q4 2022

Jan 31, 2023

BUY
$229.03 - $291.01 $4,351 - $5,529
19 Added 17.12%
130 $34,000
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $3,366 - $3,797
15 Added 15.63%
111 $25,000
Q2 2022

Aug 01, 2022

BUY
$230.71 - $256.74 $12,227 - $13,607
53 Added 123.26%
96 $23,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $1,973 - $2,183
9 Added 26.47%
43 $10,000
Q4 2021

Jan 28, 2022

BUY
$198.88 - $227.6 $6,761 - $7,738
34 New
34 $8,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Schubert & CO Portfolio

Follow Schubert & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

News

Stay updated on Schubert & CO with notifications on news.